Clinical Trial Update: Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating an attenuated SOX regimen (S-1 plus oxaliplatin) as first-line treatment for elderly patients with relapsed or metastatic gastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Soonchunhyang University Hospital | Conditions: Elderly, S-1 | Phase 2 | Status: UNKNOWN